About
I am the co-founder and CEO of Evolution Devices, a company on a mission to unlock human…
Activity
-
Today marks a significant life event for me. Today is my last day as an employee of Toyota where I get to celebrate my graduation after more than 12…
Today marks a significant life event for me. Today is my last day as an employee of Toyota where I get to celebrate my graduation after more than 12…
Liked by Pierluigi Mantovani
-
What an amazing event last night put on by the National MS Society! Thank you to Lori Espino, President of the New England Chapter, for the invite to…
What an amazing event last night put on by the National MS Society! Thank you to Lori Espino, President of the New England Chapter, for the invite to…
Liked by Pierluigi Mantovani
-
The next era of innovation in medicine is going to be about Peter Attia's "four horsemen" - neurodegenerative, cardio, cancer, and metabolic…
The next era of innovation in medicine is going to be about Peter Attia's "four horsemen" - neurodegenerative, cardio, cancer, and metabolic…
Liked by Pierluigi Mantovani
Experience
-
-
-
-
-
-
-
Education
-
University of California, Berkeley
-
Activities and Societies: Cognitive Neuroscience research, Kairos Society, Neurotech Berkeley, Latinoamericanos @ Berkeley
Honors & Awards
-
Lyfebulb & Bristol Myers Squibb Multiple Sclerosis Innovation Grant Winner
Lyfebulb & Bristol Myers Squibb
Winner & Recipient of the Lyfebulb & Bristol Myers Squibb Multiple Sclerosis Innovation Grant, which recognizes the innovation of the EvoWalk platform for people living with Multiple Sclerosis.
-
National Science Foundation Phase 1 Award
NSF
National Science Foundation (NSF) Phase 1 Grant Award given to Evolution Devices to pursue the development of our mobility technology.
-
NIH TREAT Grant Winner
NIH TREAT
1 of 2 Cohort Winners for the NIH TREAT Commercialization Grant for Evolution Devices
-
Toyota Mobility For All Finalist
Toyota
One of 5 finalists awarded a $500K grant from the Toyota Mobility Foundation.
The Toyota Mobility Foundation launched the $4 million global challenge in 2017 in partnership with Nesta’s Challenge Prize Centre, with the aim of improving the lives of millions of people with lower-limb paralysis.
The Challenge invited engineers, innovators, and designers from across the world to submit designs for
game-changing technologies, incorporating intelligent systems, to improve the mobility…One of 5 finalists awarded a $500K grant from the Toyota Mobility Foundation.
The Toyota Mobility Foundation launched the $4 million global challenge in 2017 in partnership with Nesta’s Challenge Prize Centre, with the aim of improving the lives of millions of people with lower-limb paralysis.
The Challenge invited engineers, innovators, and designers from across the world to submit designs for
game-changing technologies, incorporating intelligent systems, to improve the mobility and independence of people with lower-limb paralysis. Central to the Challenge is the importance of collaboration with endusers to develop devices which will integrate seamlessly into users’ lives and environments, while being comfortable and easy to use, enabling greater independence and increased participation in daily life.
Each of the five finalists will receive a grant of $500,000 to develop their concept further, with the final
winner of the Challenge receiving $1 million in Tokyo in 2020.
Languages
-
Spanish
Native or bilingual proficiency
-
Italian
Limited working proficiency
-
English
Native or bilingual proficiency
More activity by Pierluigi
-
What have I been up to over the past few months? A LOT. Beyond building a proper website for HealthTech Hang, in partnership with Boundary, I have…
What have I been up to over the past few months? A LOT. Beyond building a proper website for HealthTech Hang, in partnership with Boundary, I have…
Liked by Pierluigi Mantovani
-
How can we support innovators developing ground-breaking mobility solutions across society? To tackle this, we launched the Mobility Unlimited…
How can we support innovators developing ground-breaking mobility solutions across society? To tackle this, we launched the Mobility Unlimited…
Liked by Pierluigi Mantovani
-
As a Bay Area company, the Peninsula holds a special place in our history—it's where the earliest Waymonauts first envisioned a safer, more…
As a Bay Area company, the Peninsula holds a special place in our history—it's where the earliest Waymonauts first envisioned a safer, more…
Liked by Pierluigi Mantovani
-
Three years ago, I launched my workshop facilitation career in San Diego, CA talking about “expander moments”. It’s been the best ride. Thank you…
Three years ago, I launched my workshop facilitation career in San Diego, CA talking about “expander moments”. It’s been the best ride. Thank you…
Liked by Pierluigi Mantovani
-
My invention- Advanced wheelchair training device that takes the concept of wheelchair treadmills to the next level! This device allows…
My invention- Advanced wheelchair training device that takes the concept of wheelchair treadmills to the next level! This device allows…
Liked by Pierluigi Mantovani
-
We're all getting older. That's an irrefutable fact that we all have to adapt to. But here's something to consider. What does it mean to get older…
We're all getting older. That's an irrefutable fact that we all have to adapt to. But here's something to consider. What does it mean to get older…
Liked by Pierluigi Mantovani
-
So proud of to see our team at FIGUR8, Inc. Michael Oberlander, MD and Josh Williams presenting at the Hughston society conference last week!
So proud of to see our team at FIGUR8, Inc. Michael Oberlander, MD and Josh Williams presenting at the Hughston society conference last week!
Liked by Pierluigi Mantovani
-
It's no secret that the De Novo Program at FDA has a historically lower rate of success (~50%) compared its older 510(k) and PMA siblings (>85%). For…
It's no secret that the De Novo Program at FDA has a historically lower rate of success (~50%) compared its older 510(k) and PMA siblings (>85%). For…
Liked by Pierluigi Mantovani
-
#ALS is a devastating disease that my family has personally been touched by, so I was incredibly inspired to learn about a promising new treatment in…
#ALS is a devastating disease that my family has personally been touched by, so I was incredibly inspired to learn about a promising new treatment in…
Liked by Pierluigi Mantovani
-
I had a fantastic time at yesterday's session 4 of the Creative Destruction Lab (CDL-Neuro stream). CDL is an objectives-based start-up program for…
I had a fantastic time at yesterday's session 4 of the Creative Destruction Lab (CDL-Neuro stream). CDL is an objectives-based start-up program for…
Liked by Pierluigi Mantovani
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Pierluigi Mantovani
6 others named Pierluigi Mantovani are on LinkedIn
See others named Pierluigi Mantovani